Plunkett Research Online: Capstone Therapeutics Corp

CAPSTONE THERAPEUTICS CORP (CAPS:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Capstone Therapeutics Corp. is a Delaware Corporation. It is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is focused on development and commercialization of two product platforms.....



Capstone Therapeutics Corp
Ticker: CAPS
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 602 286-5520
Fax: 602 437-5524
Address: 1275 West Washington Street
Suite 104
Tempe, AZ 85281 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
John HollimanCEO/Chairman of the Board/Director
Les TaegerCFO/Chief Accounting Officer/Senior VP
See More
Capstone Therapeutics Corp. is a Delaware Corporation. It is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is focused on development and commercialization of two product platforms.....See More See More

Auditor: Eide Bailly LLP
Legal Advisor: Quarles & Brady LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: